Premium
Pulmonary Function Parameters Other Than Vital Capacity Should Be Considered in Screening for Interstitial Lung Disease in Patients With Systemic Sclerosis: Comment on the Article by Suliman et al
Author(s) -
Degano Bruno,
Soumagne Thibaud,
Eberst Guillaume,
MéauxRuault Nadine,
Gil Helder,
MagyBertrand Nadine
Publication year - 2016
Publication title -
arthritis and rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.106
H-Index - 314
eISSN - 2326-5205
pISSN - 2326-5191
DOI - 10.1002/art.39778
Subject(s) - interstitial lung disease , pulmonary function testing , medicine , lung function , intensive care medicine , disease , lung , vital capacity , scleroderma (fungus) , cardiology , function (biology) , pathology , diffusing capacity , biology , evolutionary biology , inoculation